Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
15 Feb 2019 Two Health Consortia to Develop a Detailed Feasibility Proposal for Europe’s Next €1-billion Science Projects Bioethics, legal and economic issues - Personalised medicine
14 Feb 2019 NICE Develops a Medtech Innovation Briefing on Axumin Genitourinary cancers - Diagnosis, Imaging and Staging
13 Feb 2019 Gustave Roussy and Institut Bergonié, Partners for Early Phase Trials and Therapeutic Innovation in Oncology Bioethics, legal and economic issues
12 Feb 2019 Withdrawal of the EU Marketing Authorisation Applications for Cavoley and Efgratin Palliative and supportive care
08 Feb 2019 FDA Approved Caplacizumab-yhdp Haematologic malignancies
07 Feb 2019 Companies That Make Sartan Medicines Should Review Their Manufacturing Processes to Avoid Presence of Nitrosamine Impurities Epidemiology/Etiology/Cancer Prevention
06 Feb 2019 EMA Recommends Refusal of the Marketing Authorisation for Doxolipad Anticancer agents & Biologic therapy
05 Feb 2019 EMA Adopts a New Indication for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
04 Feb 2019 EMA Recommends an Extension to One of the Existing Indications for Atezolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
01 Feb 2019 EMA Recommends Granting a Marketing Authorisation for Dacomitinib Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
30 Jan 2019 Lung Carcinoma In Situ Features Profiled Lung and other thoracic tumours - Translational research
29 Jan 2019 NICE Issues Recommendations for Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy
25 Jan 2019 Targeting Brachyury Transcription Factor Addiction in Chordoma Sarcomas - Translational research
24 Jan 2019 No New Patients Should Start Treatment with Olaratumab After ANNOUNCE Study Shows It Does Not Prolong Life Sarcomas - Anticancer agents & Biologic therapy
23 Jan 2019 NICE Recommends Nivolumab for Adjuvant Treatment of Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease Melanoma and other skin tumours - Cancer Immunology and Immunotherapy